Beck Bode LLC’s Sanofi SNY Stock Holding History

Beck Bode LLC’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-216,832	Closed	-$12.5M	–	126
2024 Q3	$12.5M	Buy	+216,832	New	+$11.7M	2.35%	24

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Beck Bode LLC's SNY Position: Q4 2024 in Review

Beck Bode LLC sold out of Sanofi (SNY) in Q4 2024, closing a stake of 216,832 shares — an estimated $12.5M sold.

Beck Bode LLC first reported a position in SNY in Q3 2024 and held it in 1 quarter. The position peaked at $12.5M in Q3 2024. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Beck Bode LLC reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Beck Bode LLC sold 216,832 Sanofi shares in Q4 2024, an estimated $12.5M.
Beck Bode LLC first reported a position in Sanofi in Q3 2024 and held it in 1 quarter.
Beck Bode LLC's Sanofi position peaked at $12.5M in Q3 2024.
732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Beck Bode LLC's 13F filing for Q4 2024, filed 14 Feb 2025.